Figure 8.
HeLa cells display an increased cellular proliferation and viability when p53 DBD Nbs are expressed. An XTT assay was performed to evaluate whether or not the p53 DBD Nb-induced stabilisation of p53 levels affects the cell viability of HeLa cells. The cells were transfected with FLAG-tagged p53 DBD Nbs or a FLAG-tagged GFP Nb (control). Thereafter, the transfected cells received (or did not receive) an additional treatment with 10 µM SAHA or 1 µM staurosporine for a duration of 20 h. The graph depicts the mean net absorbance of the formazan dye measured at 475 nm (±SEM) of triplicate samples in 4 independent experiments. Statistical analysis was performed by means of a two-way ANOVA with a Bonferroni post-test. A significant higher absorbance was measured for HeLa cells expressing the p53 DBD Nbs (p < 0.001). This result implicates that expression of p53 DBD Nbs coincided with an increased proliferation and viability of HeLa cells. When the cells were co-treated with 10 µM SAHA, there was a decline in cellular proliferation. However, there was still a significant difference between HeLa cells expressing a p53 DBD Nb and the control condition (p < 0.001). The cell viability was dramatically reduced for all conditions when the cells were co-treated with 1 µM staurosporine.